GINKGO BIOWORKS HOLDINGS, INC. (DNA-WT) Financial Statements
GINKGO BIOWORKS HOLDINGS, INC. (DNA-WT) files with the U.S. Securities and Exchange Commission under CIK 0001830214. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $170.16 million
- Net Income
- -$312.76 million
- Total Assets
- $1.12 billion
- Net Cash from Operations
- -$171.06 million
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 6, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for DNA-WT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History